Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Hammel

Showing results (151-160 of 241) with videos related to

Pageof 25
Sort By:
Annals of Internal Medicine|May 19, 2015
Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series studyLouis de Mestier, Olivia Hentic, Jérôme Cros, et al.
Neuroendocrinology|December 3, 2019
The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine TumorsLouis de Mestier, Anne-Laure Védie, Matthieu Faron, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2006
Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancyPhilippe Lévy, Vincent Jouannaud, Dermot O'Toole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2020
Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic AdenocarcinomaJean-Baptiste Bachet, Hélène Blons, Pascal Hammel, et al.
Gastrointestinal Endoscopy|June 3, 2004
Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesionsDermot O'Toole, Laurent Palazzo, Pascal Hammel, et al.
Acta Oncologica (Stockholm, Sweden)|June 23, 2016
Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancersSihem Sebbagh, Julia Roux, Chantal Dreyer, et al.
Oncotarget|June 15, 2018
Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer processDorothée Faille, Marie-Charlotte Bourrienne, Emmanuelle de Raucourt, et al.
European Journal of Endocrinology|August 5, 2023
OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogelVincent Hautefeuille, Thomas Walter, Christine Do Cao, et al.
Gastroenterologie Clinique Et Biologique|November 4, 2004
Pancreatic metastases: a multicentric study of 22 patientsAbdallah Moussa, Emmanuel Mitry, Pascal Hammel, et al.
Molecular Cancer Therapeutics|April 22, 2010
Epithelial-to-mesenchymal transition and oncogenic Ras expression in resistance to the protein kinase Cbeta inhibitor enzastaurin in colon cancer cellsMaria Serova, Lucile Astorgues-Xerri, Ivan Bieche, et al.
Pageof 25

Showing results (151-160 of 241) with videos related to

Sort By:
Pageof 25
Annals of Internal Medicine|May 19, 2015
Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series studyLouis de Mestier, Olivia Hentic, Jérôme Cros, et al.
Neuroendocrinology|December 3, 2019
The Postoperative Occurrence or Worsening of Diabetes Mellitus May Increase the Risk of Recurrence in Resected Pancreatic Neuroendocrine TumorsLouis de Mestier, Anne-Laure Védie, Matthieu Faron, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2006
Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancyPhilippe Lévy, Vincent Jouannaud, Dermot O'Toole, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 2020
Circulating Tumor DNA is Prognostic and Potentially Predictive of Eryaspase Efficacy in Second-line in Patients with Advanced Pancreatic AdenocarcinomaJean-Baptiste Bachet, Hélène Blons, Pascal Hammel, et al.
Gastrointestinal Endoscopy|June 3, 2004
Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesionsDermot O'Toole, Laurent Palazzo, Pascal Hammel, et al.
Acta Oncologica (Stockholm, Sweden)|June 23, 2016
Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancersSihem Sebbagh, Julia Roux, Chantal Dreyer, et al.
Oncotarget|June 15, 2018
Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer processDorothée Faille, Marie-Charlotte Bourrienne, Emmanuelle de Raucourt, et al.
European Journal of Endocrinology|August 5, 2023
OPERA: perception of information in patients with gastroenteropancreatic neuroendocrine tumors on lanreotide autogelVincent Hautefeuille, Thomas Walter, Christine Do Cao, et al.
Gastroenterologie Clinique Et Biologique|November 4, 2004
Pancreatic metastases: a multicentric study of 22 patientsAbdallah Moussa, Emmanuel Mitry, Pascal Hammel, et al.
Molecular Cancer Therapeutics|April 22, 2010
Epithelial-to-mesenchymal transition and oncogenic Ras expression in resistance to the protein kinase Cbeta inhibitor enzastaurin in colon cancer cellsMaria Serova, Lucile Astorgues-Xerri, Ivan Bieche, et al.
Pageof 25